Karisalai ennai (Internal) and Aavaraiver ennai (External) in the management of Karappan (Eczema) in children

Clinical evaluation of Karisalai ennai (Internal) and Aavaraiver ennai (external) in the management of Karappan in Children

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/06/026084

Enrollment

Registered

2020-06-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

Intervention1: Karisalai ennai- Internal Aavaraiver ennai- External: Karisalai ennai- Internal 7-9 years 5 ml(od) 10-12 years 10 ml(od) Aavaraiver ennai - External As per need Duration - 21

Eligibility

Inclusion criteria

Inclusion criteria: Children of both sexes in the age group of 7 to 12 years with symptoms of: ï?? Erythema ï?? Edema ï?? Oozing ï?? Itching ï?? Crusting and scaling ï?? Lichentified plaque ï?? Willing to give Biological samples whenever necessary.

Exclusion criteria

Exclusion criteria: ï?? Scabies ï?? Photodermatitis ï?? Fungal and parasitic skin infection ï?? Psoriasis ï?? Any other serious illness

Design outcomes

Primary

Measure	Time frame
Efficacy of the trial drug is measured by using EASI SCORE and Improvement in the clinical condition will be observed. Timepoint: 12 months	—

Secondary

Measure	Time frame
Reduction in the recurrence of the disease and improvement in the quality of life of children. Timepoint: 12 months	—

Countries

India

Contacts

Public ContactDr M Meenakshi Sundaram

National institute of Siddha

drsureshherbal@gmail.com9962571137

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026